(4S,4'S)-4,4'-Di((S)-sec-butyl)-4,4',5,5'-tetrahydro-2,2'-bioxazole, 97%, 1g

6-methyl-5H-[1,2,4]triazino[5,6-b]indole-3-thiol, 95.0%, 1g

3-(1,3-Dioxan-2-yl)aniline, 97.0%, 5g

2-(2,4-Diaminophenoxy)ethanol Dihydrochloride>98.0%(HPLC)(T)5g

THIAZOLO[5,4-C]PYRIDINE-2-THIOL, 95.0%, 5g

4-Amino-2,6-difluorophenol hydrochloride, 95.0%, 5g

4-Chloro-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 2.5g

6-Morpholin-4-ylpyrazine-2-carboxylic acid, 97.0%, 1g

(2E)-1-(4-ethylphenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

3-Aminobenzoic acid hydrochloride, 95.0%, 25g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indoline, 97%, 250mg

2-Chloro-5-fluorobenzamide, 97.0%, 250mg

Colonna capillare per GC ROTI®Cap-1701, 10 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)